Dengue vaccine – Greenbook Summary

Vaccine Description and Composition “The dengue vaccination Qdenga® is a tetravalent live attenuated vaccine. It is produced in Vero cells by recombinant DNA technology and contains serotype-specific surface protein genes of the four dengue serotypes, engineered into a dengue type 2 backbone.” Storage and Presentation “Vaccines should be stored in the original packaging at +2C̊…

Read More

Shingles vaccine: study note

Two licensed shingles vaccines are available in the UK: Zostavax® and Shingrix®. Zostavax® Shingrix® Live vaccine? Live attenuated vaccine Recombinant vaccine (Not live) Strain/ component Derived from the OKA/Merck strain of the Varicella Zoster Virus Contains varicella-zoster virus glycoprotein E antigen produced by recombinant DNA technology, adjuvanted with AS01B Route The vaccine is given IM or Subcutaneous, preferably in the…

Read More

Japanese encephalitis vaccine: study note

Vaccine Inactivated vaccine (IXIARO®), NO live virus.Adjuvant: Aluminium hydroxide (improves immunogenicity).Storage: +2°C to +8°C and protected from light. Administration Primary immunisation Primary immunisation should ideally be completed at least one week before potential exposure to the Japanese encephalitis virus. Full immunity takes up to one week to develop after the second dose. Standard schedule Rapid schedule 1st dose…

Read More

Rotavirus vaccine (study note)

Vaccine Efficacy– Protect against gastroenteritis due to rotavirus serotypes G1P, G2P, G3P, G4P, and G9P; some efficacy against uncommon rotavirus genotypes G8P and G12P.– Over 85% effective at protecting against severe rotavirus gastroenteritis in the first two years of life. Administration of the vaccine Rotarix® should not be given to infants under 6 weeks of age.WHO recommends infants should…

Read More